Oral Corticosteroid Duration for Acute Asthma Exacerbations
For adults with acute asthma exacerbations, prescribe oral prednisone 40–60 mg daily for 5–10 days without tapering; for children, prescribe prednisolone 1–2 mg/kg/day (maximum 60 mg) for 3–10 days without tapering. 1
Adult Dosing Algorithm
Standard outpatient regimen:
- Prednisone 40–60 mg once daily (or divided into two doses) for 5–10 days 1, 2
- Continue treatment until peak expiratory flow (PEF) reaches ≥70% of predicted or personal best 1
- No tapering is required for courses lasting less than 7–10 days, especially when patients are concurrently taking inhaled corticosteroids 1, 2
Severity-based dosing:
- Moderate exacerbations (PEF 40–69%): 40–60 mg daily 1
- Severe exacerbations (PEF <40% or requiring hospitalization): 40–80 mg daily until PEF reaches ≥70% 1
Pediatric Dosing Algorithm
Standard regimen:
- Prednisolone or prednisone 1–2 mg/kg/day in two divided doses (maximum 60 mg/day) for 3–10 days 1, 2
- For overweight children, calculate dose using ideal body weight (approximately 25–30 kg for an 8-year-old) to avoid excessive steroid exposure 1
- Continue until PEF reaches ≥70% of predicted or personal best 1
- No tapering is necessary for courses shorter than 7–10 days 1
Evidence Supporting Duration
The evidence strongly supports 5–10 days as the standard duration for outpatient management:
- A randomized controlled trial comparing 5-day versus 3-day courses in children found no difference in symptom resolution at Day 7, but the difference fell within the equivalence range, suggesting 5 days may be optimal 3
- The Cochrane systematic review (2016) found insufficient evidence to recommend shorter courses over longer courses, with no convincing differences in outcomes between regimens 4
- Historical evidence from 1983 demonstrated that an 8-day tapering course reduced relapse rates (5.9% vs 21% for placebo) and respiratory symptoms compared to placebo 5
The 5–10 day range represents the evidence-based standard, with 5 days being typical for uncomplicated outpatient exacerbations and up to 10 days (or longer) for severe cases where lung function has not returned to baseline 1, 2
Critical Clinical Pitfalls to Avoid
Do not use arbitrarily short 3-day courses:
- While some studies suggest 3 days may be equivalent to 5 days, the evidence is not strong enough to recommend this as standard practice 3
- Using courses shorter than 5 days without assessing clinical response may result in treatment failure 1
Do not taper short courses:
- Tapering courses lasting less than 7–10 days is unnecessary and may lead to underdosing during the critical recovery period 1, 2, 6
- A 1995 randomized trial demonstrated no benefit to tapering prednisolone after recovery, provided treatment continued until stable PEF was achieved 6
- The hypothalamic-pituitary-adrenal axis remains intact with short "burst" courses, even when given multiple times per year 7
Do not stop prematurely:
- Treatment must continue until objective improvement is documented (PEF ≥70% of predicted or personal best), not for an arbitrary fixed duration 1
- For severe exacerbations, treatment may need to extend up to 21 days until lung function returns to the patient's previous best 1
Route of Administration
- Oral administration is strongly preferred and equally effective as intravenous therapy when gastrointestinal absorption is intact 1, 2
- Reserve IV hydrocortisone (200 mg initially, then 200 mg every 6 hours) for patients who are vomiting, severely ill, or unable to tolerate oral medications 1